In a fit of hubris, President Trump believes he is making drug makers “come clean” by forcing them to mention list prices in their TV ads.
If only it were that simple.
The reality is that last week’s mandate may, indeed, prod recalcitrant drug makers to pay more attention to pricing and, in some cases, cast this or that company in a greedy light. But for the most part, the numbers that will soon flash across screens are likely to be confusing and, in many cases, irrelevant.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.